Why Humacyte Stock Is Trading 15% Higher Monday

Benzinga41minutes ago

Humacyte Stock Rallies 19% on FDA RMAT Designation

Seeking AlphaJul 1 23:06

Humacyte Announces Third RMAT Designation By FDA For ATEV - Quick Facts

RTTNewsJul 1 21:33

Humacyte Shares Jump on FDA's Special Status Award

WSJJul 1 21:12

Humacyte's ATEV Treatment Gets New FDA Designation; Shares Rise Pre-Bell

MT NewswiresJul 1 20:45

Express News | Humacyte Acellular Tissue Engineered Vessel (Atev™) Receives Fda’s Regenerative Medicine Advanced Therapy (Rmat) Designation for Patients With Advanced Peripheral Artery Disease (Pad)

BreakingsJul 1 20:01